Integrating Optune Gio into Practice

In 4 steps, MyNovocure™ helps you easily integrate
Optune Gio™ into your practice

Click on these 4 steps to help you integrate Optune Gio into your practice

DISCUSS treatment plan with multidisciplinary team, patient, and caregiver

  • A coordinated approach with your multidisciplinary team is key for ensuring consistent communication with patients and caregivers.
  • Present Optune Gio in a way that addresses your patient’s needs and concerns.
  • Remind patients and caregivers about the support available to them through MyNovocure™.
  • Recommend the Buddy Program. It allows your patients to speak with current Optune Gio users who can share their personal experiences using Optune Gio. Go to Optune Buddy Program Enrollment.
  • Reinforce the treatment plan at subsequent visits.

Managing GBM remotely? Optune Gio continues to be a viable treatment choice

These telemedicine best practices have been developed to address the evolving nature of patient care.

1. Scheduling

  • Have a dedicated staff for scheduling
  • Obtain verbal consent from patients
  • Remind patients that the appointment start time may vary

2. Preparation

  • Dial in to the virtual platform early to address potential technical issues
  • Pull up all files to be shared in advance

3. Conducting

  • Have participants introduce themselves (can include caregiver)
  • Speak slowly, clearly, and concisely
  • Encourage patients and/or caregivers to take notes
  • Leave time for patients and caregivers to ask questions

4. Concluding

  • Have the patient and/or caregiver read back the counsel provided
  • Determine if telemedicine is right for the individual patient

Contact MyNovocure for all your practice and patient support needs

Call us any time of day:

Help connect your patients to helpful Optune Gio patient support resources

Patient Support
Learn more about suggested management for AEs

Indications For Use


Optune GioTM is intended as a treatment for adult patients (22 years of age or older) with histologically confirmed glioblastoma multiforme (GBM).


Optune Gio with temozolomide is indicated for the treatment of adult patients with newly diagnosed, supratentorial glioblastoma following maximal debulking surgery, and completion of radiation therapy together with concomitant standard of care chemotherapy.


For the treatment of recurrent GBM, Optune Gio is indicated following histologically or radiologically confirmed recurrence in the supratentorial region of the brain after receiving chemotherapy. The device is intended to be used as a monotherapy and is intended as an alternative to standard medical therapy for GBM after surgical and radiation options have been exhausted.

Important Safety Information



Do not use Optune Gio in patients with an active implanted medical device, a skull defect (such as, missing bone with no replacement), or bullet fragments. Use of Optune Gio together with implanted electronic devices has not been tested and may theoretically lead to malfunctioning of the implanted device. Use of Optune Gio together with skull defects or bullet fragments has not been tested and may possibly lead to tissue damage or render Optune Gio ineffective.


Do not use Optune Gio in patients that are known to be sensitive to conductive hydrogels. In this case, skin contact with the gel used with Optune Gio may commonly cause increased redness and itching, and rarely may even lead to severe allergic reactions such as shock and respiratory failure.


Warnings and precautions


Optune Gio can only be prescribed by a healthcare provider that has completed the required certification training provided by Novocure (the device manufacturer).


Do not prescribe Optune Gio for patients that are pregnant, you think might be pregnant or are trying to get pregnant, as the safety and effectiveness of Optune Gio in these populations have not been established.


The most common (≥10%) adverse events involving Optune Gio in combination with temozolomide were thrombocytopenia, nausea, constipation, vomiting, fatigue, medical device site reaction, headache, convulsions, and depression.


The most common (≥10%) adverse events seen with Optune Gio monotherapy were medical device site reaction and headache.
The following adverse reactions were considered related to Optune Gio when used as monotherapy: medical device site reaction, headache, malaise, muscle twitching, fall, and skin ulcer.


Use of Optune Gio in patients with an inactive implanted medical device in the brain has not been studied for safety and effectiveness, and use of Optune Gio in these patients could lead to tissue damage or lower the chance of Optune Gio being effective.


If the patient has an underlying serious skin condition on the scalp, evaluate whether this may prevent or temporarily interfere with Optune Gio treatment.


Please click here to see the Optune GioTM Instructions For Use for complete information regarding the device's indications, contraindications, warnings, and precautions.

Novocure Websites

This website is intended for people seeking information on Optune Gio.

On this site, videos and images identified as Optune Gio users, caregivers, or healthcare professionals depict actual patients, caregivers, and healthcare professionals.

Patient images reflect the health status of the patients at the time each photo or video was taken.


©2023 Novocure GmbH. All Rights Reserved. 

Optune, Optune Gio, MyNovocure, NovoTAL, and Novocure are trademarks of Novocure GmbH. 

All other trademarks, registered or unregistered, are the property of their respective owners. 

US-OPG-00197v1.0 November 2023